Toll Free: 1-888-928-9744
Published: Apr, 2022 | Pages:
319 | Publisher: The Business Research Company
Industry: Pharmaceutical | Report Format: Electronic (PDF)
Anti-Asthmatics And COPD Drugs Global Market Opportunities And Strategies To 2030: COVID 19 Implications and Growth report from The Business Research Company provides the strategists, marketers and senior management with the critical information they need to assess the demand for anti-asthmatics and COPD drugs market which play a critical role in the treatment of patients with Covid 19. Description: Where is the largest and fastest growing market for the anti-asthmatics and COPD drugs market? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward? The global anti-asthmatics and COPD drugs market opportunities and strategies to 2030: COVID 19 Implications and Growth report from the Business Research Company answers all these questions and many more. The report covers the following chapters 1. Executive Summary -The executive summary section of the report gives a brief overview and summary of the report. 2. Report Structure - This section gives the structure of the report and the information covered in the various sections. 3. Introduction -The introduction section of the report gives brief introduction about segmentation by geography and segmentation by type. 4. Market Characteristics -The market characteristics section of the report defines and explains the anti-asthmatics and COPD drugs market. This chapter includes different goods covered in the report and basic definitions. 5. Supply Chain -The supply chain section of the report defines and explains the key players in the anti-asthmatics and COPD drugs industry supply chain. 6. Product Analysis -The product analysis section of the report describes the leading products in the market along with key features and differentiators for those products. 7. Top 10 Leading Drugs Sales-The section describes list of top 10 drugs and their sales in the anti-asthmatics and COPD drug market in 2019. It briefs on the drug chemical composition, drug class and the manufacturers involved in manufacturing and selling of these leading drugs in the anti-asthmatics and COPD drugs market. 8. Patent Analysis Of Leading Drugs-The section briefs on the patent analysis of the leading drugs in the anti-asthmatics and COPD drugs market, by focusing on the leading drugs’ patent expiry and emergence of the generic drugs in the market. 9. Customer Information- This chapter covers recent customers’ trends/preferences in the global anti-asthmatics and COPD drugs market. 10. Impact Of COVID-19- This section describes the impact of COVID-19 on the anti-asthmatics and COPD drugs market. 11. Trends And Strategies - This chapter describes the major trends shaping the global anti-asthmatics and COPD drugs market. This section highlights likely future developments in the market and suggests approaches companies can take to exploit these opportunities. 12. Asthma And COPD Prevalence Overview-This section describes about asthma and COPD and their prevalence in the major countries. 13. Global Market Size And Growth - This section contains the global historic (2015-2019) and forecast (2019 - 2023, 2025 and 2030) market values, and drivers and restraints that support and restrain the growth of the market in the historic and forecast periods. 14. Regional And Country Analysis - This section contains the historic (2015-2019), forecast (2023, 2025 and 2030) market value and growth and market share comparison by region and countries. 15. Market Segmentation -This section contains the market values (2015-2029, 2023, 2025 and 2030) and analysis for different segments in the market. 16. Regional Market Size And Growth-This section contains the region’s market size (2019), historic and forecast (2015-2019, 2023, 2025 and 2030) market values, and growth and market share comparison of major countries within the region. This report includes information on all the regions (Asia Pacific, Western Europe, Eastern Europe, North America, South America, Middle East and Africa). 17. Competitive Landscape - This section covers details on the competitive landscape of the global anti-asthmatics and COPD drugs market, estimated market shares and company profiles of the leading players. 18. Key Mergers And Acquisitions - This chapter gives the information on recent mergers and acquisitions in the market covered in the report. This section gives key financial details of mergers and acquisitions which have shaped the market in recent years. 19. Market Background - This section describes the respiratory diseases drugs market of which the anti-asthmatics and COPD drugs market is a segment. This chapter includes the respiratory diseases drugs market 2015-23 values, and regional analyses for the respiratory diseases drugs market. 20. Market Opportunities And Strategies- This section includes market opportunities and strategies based on findings of the research. This section also gives information on growth opportunities across countries, segments and strategies to be followed in those markets. It gives an understanding of where there is significant business to be gained by competitors in the next five years. 21. Conclusions And Recommendations - This section includes conclusions and recommendations based on findings of the research. This section also gives recommendations for anti-asthmatics and COPD drugs providers in terms of product offerings, geographic expansion, price offerings, marketing strategies and target groups. 22. Appendix - This section includes details on the NAICS codes covered, abbreviations and currencies codes used in this report. Markets Covered: • By Type Of Drug Class: Combination Drugs; Bronchodilators; Monoclonal Antibodies; Anti-Inflammatory Drugs • By Type Of End-User: Asthma Patients; COPD Patients • By Distribution Channel: General Pharmacies; Hospital Pharmacies; Online Retailers • By Age Group: Below 5 Years; 5 to 14 Years; 15-69 Years; 70+ Years • By Type Of Therapy: Preventive; Curative • By Route Of Administration: Inhaled; Intravenous and Subcutaneous; Oral • By Type Of Prescription: Prescription; OTC • By Type Of Drug: Branded; Generics Companies Mentioned: GlaxoSmithKline plc.; AstraZeneca plc.; Boehringer Ingelheim; F. Hoffmann-La Roche Ltd; Novartis Countries: China, India, Japan, Australia, Indonesia, South Korea, USA, Russia, UK, Germany, France, Brazil. Regions: Asia Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa. Time series: Two five-year periods, one three-year period and one six-year period. Data: Ratios of market size and growth to related markets, GDP proportions, expenditure per capita Data segmentations: country and regional historic and forecast data, market share of competitors, market segments. Sourcing and Referencing: Data and analysis throughout the report is sourced using end notes. Reasons to Purchase • Outperform competitors using accurate up to date demand-side dynamics information. • Understand how the market is experiencing rapid growth due to the coronavirus and how it is likely to stabilize as the impact of the virus abates. • Identify growth segments for investment. • Facilitate decision making on the basis of historic and forecast data and the drivers and restraints on the market. • Create regional and country strategies on the basis of local data and analysis. • Stay abreast of the latest customer and market research findings • Benchmark performance against key competitors. • Develop strategies based on likely future developments. • Utilize the relationships between key data sets for superior strategizing. • Suitable for supporting your internal and external presentations with reliable high quality data and analysis • Gain a global perspective on the development of the market.
Table of Content 1. Anti-Asthmatics And COPD Drugs Market Executive Summary 2. Table of Contents 3. List of Figures 4. List of Tables 5. Report Structure 6. Introduction 6.1.1. Segmentation By Geography 6.1.2. Segmentation By Drug Class 6.1.3. Segmentation By End User 6.1.4. Segmentation By Distribution Channel 6.1.5. Segmentation By Therapy 6.1.6. Segmentation By Route Of Administration 6.1.7. Segmentation By Age Group 6.1.8. Segmentation By Prescription 6.1.9. Segmentation By Drug Type 7. Anti-Asthmatics And COPD Drugs Market Characteristics 7.1. Market Segmentation By Class 7.1.1. Bronchodilators 7.1.2. Anti-Inflammatory Drugs 7.1.3. Monoclonal Antibodies 7.1.4. Combination Drugs 7.2. Market Segmentation By End User 7.2.1. Asthma Patients 7.2.2. COPD Patients 7.3. Market Segmentation By Distribution Channel 7.3.1. Hospital Pharmacies 7.3.2. General Pharmacies 7.3.3. Online Retailers 7.4. Market Segmentation By Therapy 7.4.1. Preventive 7.4.2. Curative 7.5. Market Segmentation By Route Of Administration 7.5.1. Oral 7.5.2. Inhaled 7.5.3. Intravenous 7.5.4. Subcutaneous 7.6. Market Segmentation By Age Group 7.6.1. Below 5 7.6.2. 5-14 7.6.3. 15-60 7.6.4. Above 60 7.7. Market Segmentation By Prescription 7.7.1. Prescription 7.7.2. Over The Counter (OTC) 7.8. Market Segmentation By Drug Type 7.8.1. Branded 7.8.2. Generic 8. Anti-Asthmatics And COPD Drugs Market, Supply Chain Analysis 8.1.1. Raw Material And Equipment Procurement 8.1.2. Manufacturing, Processing and Packaging 8.1.3. Distribution 8.1.4. Physicians 8.1.5. End users 9. Anti-Asthmatics And COPD Drugs Market, Product Pipeline Analysis 10. Anti-Asthmatics And COPD Drugs Market, Top 10 Leading Drugs Sales 10.1.1. Ellipta 10.1.2. Spiriva 10.1.3. Symbicort 10.1.4. Advair 10.1.5. Pulmicort 10.1.6. Ventolin 10.1.7. Xolair 10.1.8. Nucala 10.1.9. Flovent 10.1.10. Fasenra 11. Anti-Asthmatics And COPD Drugs Market, Patent Analysis Of Leading Drugs 11.1.1. Background 11.1.2. Innovators 12. Anti-Asthmatics And COPD Drugs Market, Customer Information 12.1. Majority Of Australian COPD Patients Are Physically Inactive And Obese 12.2. Britons Experience Inadequate Treatment Of COPD 12.3. COPD Patients Are More Likely To Be Current Daily Smokers Or Ex-Smokers 12.4. Uncontrolled Asthma Patients Face Recurring Symptoms And Doctor Visits 12.5. Uncontrolled Asthma Patients Struggle With Mobility Issues 13. Impact of COVID-19 On The Anti-Asthmatics And COPD Drugs Market 13.1. Consumer Perception 13.2. High Mortality Among Asthma Patients 13.3. Anti-Asthmatic And COPD Drugs Used In COVID-19 Treatment 14. Anti-Asthmatics And COPD Drugs Market Regulatory Landscape 14.1.1. India 14.1.2. China 14.1.3. Japan 14.1.4. Australia 14.1.5. South Korea 14.1.6. Indonesia 14.1.7. USA 14.1.8. Canada 14.1.9. Mexico 14.1.10. UK 14.1.11. Germany 14.1.12. France 14.1.13. Russia 14.1.14. Brazil 15. Anti-Asthmatics And COPD Drugs Market Trends And Strategies 15.1. Collaborations In The Anti-Asthmatics and COPD Drugs Market 15.2. Increasing Demand For Personalized Medicines 15.3. Demand For Aerosol Respiratory Drugs 15.4. Use Of Biomarker For Precision Medicine 15.5. Rise Of Generic Respiratory Drugs 15.6. Combination Drug Therapy To Treat COPD 15.7.New Biologic Therapy Medicines To Treat Severe Asthma 16. Asthma And COPD Prevalence Overview 16.1. Asthma 16.2. COPD 17. Global Anti-Asthmatics And COPD Drugs Market Size And Growth 17.1. Market Size 17.2. Historic Market Growth, 2015 – 2019, Value ($ Million) 17.2.1. Historic Drivers Of The Market 2015-2019 17.2.2. Historic Restraints Of The Market 2015-2019 17.3. Forecast Market Growth, 2019 – 2023, 2025F, 2030F Value ($ Million) 17.3.1. Forecast Drivers Of The Market 2019-2023 17.3.2. Forecast Restraints Of The Market 2019-2023 18. Anti-Asthmatics And COPD Drugs Market, Regional And Country Analysis 18.1. Global Anti-Asthmatics And COPD Drugs Market, By Region, Historic and Forecast, 2015 – 2019, 2023F, 2025F, 2030F, Value ($ Million) 18.2. Global Anti-Asthmatics And COPD Drugs Market, By Country, Historic and Forecast, 2015 – 2019, 2023F, 2025F, 2030F, Value ($ Million) 19. Global Anti-Asthmatics And COPD Drugs Market Segmentation 19.1. Global Anti-Asthmatics And COPD Drugs Market, Segmentation By Drug Class, Historic And Forecast, 2015 – 2019, 2023F, 2025F, 2030F, Value ($ Million) 19.1.1. Combination Drugs 19.1.2. Bronchodilators 19.1.3. Monoclonal Antibodies 19.1.4. Anti-Inflammatory Drugs 19.2. Global Anti-Asthmatics And COPD Drugs Market, Segmentation By End Users, Historic And Forecast, 2015 – 2019, 2023F, 2025F, 2030F, Value ($ Million) 19.2.1. Asthma Patients 19.2.2. COPD Patients 19.3. Global Anti-Asthmatics And COPD Drugs Market, Segmentation By Distribution Channel, Historic And Forecast, 2015 – 2019, 2023F, 2025F, 2030F, Value ($ Million) 19.3.1. General Pharmacies 19.3.2. Hospital Pharmacies 19.3.3. Online Retailers 19.4. Global Anti-Asthmatics And COPD Drugs Market, Segmentation By Therapy, 2019, Value ($ Million) 19.4.1. Preventive 19.4.2. Curative 19.5. Global Anti-Asthmatics And COPD Drugs Market, Segmentation By Route Of Administration, 2019, Value ($ Million) 19.5.1. Inhaled 19.5.2. Intravenous and Subcutaneous 19.5.3. Oral 19.6. Global Anti-Asthmatics And COPD Drugs Market, Segmentation By Patients’ Age Group, 2019, Value ($ Million) 19.6.1. 15-69 Years 19.6.2. 70+ Years 19.6.3. Below 5 Years 19.7. Global Anti-Asthmatics And COPD Drugs Market, Segmentation By Type Of Prescription, 2019, Value ($ Million) 19.7.1. Prescription 19.7.2. OTC 19.8. Global Anti-Asthmatics And COPD Drugs Market, Segmentation By Type Of Drug, 2019, Value ($ Million) 19.8.1. Branded 19.8.2. Generics 20. Asia-Pacific Anti-Asthmatics And COPD Drugs Market 20.1. Asia-Pacific Anti-Asthmatics And COPD Drugs Market Overview 20.1.1. Region Information 20.1.2. Market Information 20.1.3. Background Information 20.1.4. Government Initiatives 20.1.5. New Drug Trials And Approvals 20.1.6. Major Associations 20.1.7. Taxes Levied 20.1.8. Investments 20.1.9. Major Companies 20.2. Asia-Pacific Anti-Asthmatics And COPD Drugs Market, Historic Market Growth, 2015 – 2019, Value ($ Million) 20.3. Asia-Pacific Anti-Asthmatics And COPD Drugs Market, Forecast Market Growth, 2019 – 2023, 2025F, 2030F Value ($ Million) 20.4. Asia-Pacific Anti-Asthmatics And COPD Drugs Market, Segmentation By Drug Class, Historic And Forecast, 2015 – 2019, 2023F, 2025F, 2030F, Value ($ Million) 20.5. Asia-Pacific Anti-Asthmatics And COPD Drugs Market, Segmentation By End Users, Historic And Forecast, 2015 – 2019, 2023F, 2025F, 2030F, Value ($ Million) 20.6. Asia-Pacific Anti-Asthmatics And COPD Drugs Market: Country Analysis 20.7. China Anti-Asthmatics And COPD Drugs Market 20.8. China Anti-Asthmatics And COPD Drugs Market Overview 20.8.1. Country Information 20.8.2. Market Information 20.8.3. Background Information 20.8.4. Government Initiatives 20.8.5. New Drug Trials And Approvals 20.8.6. Major Associations 20.8.7. Taxes Levied 20.8.8. Investments 20.8.9. Major Companies 20.9. China Anti-Asthmatics And COPD Drugs Market, Historic Market Growth, 2015 – 2019, Value ($ Million) 20.10. China Anti-Asthmatics And COPD Drugs Market, Forecast Market Growth, 2019 – 2023, 2025F, 2030F Value ($ Million) 20.11. China Anti-Asthmatics And COPD Drugs Market, Segmentation By Drug Class, Historic And Forecast, 2015 – 2019, 2023F, 2025F, 2030F, Value ($ Million) 20.12. China Anti-Asthmatics And COPD Drugs Market, Segmentation By End Users, Historic And Forecast, 2015 – 2019, 2023F, 2025F, 2030F, Value ($ Million) 20.13. India Anti-Asthmatics And COPD Drugs Market 20.14. India Anti-Asthmatics And COPD Drugs Market Overview 20.14.1. Country Information 20.14.2. Market Information 20.14.3. Background Information 20.14.4. Government Initiatives 20.14.5. Major Associations 20.14.6. Taxes Levied 20.14.7. Investments 20.14.8. Major Companies 20.15. India Anti-Asthmatics And COPD Drugs Market, Historic Market Growth, 2015 – 2019, Value ($ Million) 20.16. India Anti-Asthmatics And COPD Drugs Market, Forecast Market Growth, 2019 – 2023, 2025F, 2030F Value ($ Million) 20.17. India Anti-Asthmatics And COPD Drugs Market, Segmentation By Drug Class, Historic And Forecast, 2015 – 2019, 2023F, 2025F, 2030F, Value ($ Million) 20.18. India Anti-Asthmatics And COPD Drugs Market, Segmentation By End Users, Historic And Forecast, 2015 – 2019, 2023F, 2025F, 2030F, Value ($ Million) 20.19. Japan Anti-Asthmatics And COPD Drugs Market 20.20. Japan Anti-Asthmatics And COPD Drugs Market Overview 20.20.1. Country Information 20.20.2. Market Information 20.20.3. Background Information 20.20.4. Government Initiatives 20.20.5. New Drug Trials And Approvals 20.20.6. Major Associations 20.20.7. Taxes Levied 20.20.8. Investments 20.20.9. Major Companies 20.21. Japan Anti-Asthmatics And COPD Drugs Market, Historic Market Growth, 2015 – 2019, Value ($ Million) 20.22. Japan Anti-Asthmatics And COPD Drugs Market, Forecast Market Growth, 2019 – 2023, 2025F, 2030F Value ($ Million) 20.23. Japan Anti-Asthmatics And COPD Drugs Market, Segmentation By Drug Class, Historic And Forecast, 2015 – 2019, 2023F, 2025F, 2030F, Value ($ Million) 20.24. Japan Anti-Asthmatics And COPD Drugs Market, Segmentation By End Users, Historic And Forecast, 2015 – 2019, 2023F, 2025F, 2030F, Value ($ Million) 20.25. Australia Anti-Asthmatics And COPD Drugs Market 20.26. Australia Anti-Asthmatics And COPD Drugs Market, Historic Market Growth, 2015 – 2019, Value ($ Million) 20.27. Australia Anti-Asthmatics And COPD Drugs Market, Forecast Market Growth, 2019 – 2023, 2025F, 2030F Value ($ Million) 20.28. Australia Anti-Asthmatics And COPD Drugs Market, Segmentation By Drug Class, Historic And Forecast, 2015 – 2019, 2023F, 2025F, 2030F, Value ($ Million) 20.29. Australia Anti-Asthmatics And COPD Drugs Market, Segmentation By End Users, Historic And Forecast, 2015 – 2019, 2023F, 2025F, 2030F, Value ($ Million) 20.30. Indonesia Anti-Asthmatics And COPD Drugs Market 20.31. Indonesia Anti-Asthmatics And COPD Drugs Market, Historic Market Growth, 2015 – 2019, Value ($ Million) 20.32. Indonesia Anti-Asthmatics And COPD Drugs Market, Forecast Market Growth, 2019 – 2023, 2025F, 2030F Value ($ Million) 20.33. Indonesia Anti-Asthmatics And COPD Drugs Market, Segmentation By Drug Class, Historic And Forecast, 2015 – 2019, 2023F, 2025F, 2030F, Value ($ Million) 20.34. Indonesia Anti-Asthmatics And COPD Drugs Market, Segmentation By End Users, Historic And Forecast, 2015 – 2019, 2023F, 2025F, 2030F, Value ($ Million) 20.35. South Korea Anti-Asthmatics And COPD Drugs Market 20.36. South Korea Anti-Asthmatics And COPD Drugs Market, Historic Market Growth, 2015 – 2019, Value ($ Million) 20.37. South Korea Anti-Asthmatics And COPD Drugs Market, Forecast Market Growth, 2019 – 2023, 2025F, 2030F Value ($ Million) 20.38. South Korea Anti-Asthmatics And COPD Drugs Market, Segmentation By Drug Class, Historic And Forecast, 2015 – 2019, 2023F, 2025F, 2030F, Value ($ Million) 20.39. South Korea Anti-Asthmatics And COPD Drugs Market, Segmentation By End Users, Historic And Forecast, 2015 – 2019, 2023F, 2025F, 2030F, Value ($ Million) 21. Western Europe Anti-Asthmatics And COPD Drugs Market 21.1. Western Europe Anti-Asthmatics And COPD Drugs Market Overview 21.1.1. Region Information 21.1.2. Market Information 21.1.3. Background Information 21.1.4. Government Initiatives 21.1.5. New Drug Trials And Approvals 21.1.6. Major Associations 21.1.7. Taxes Levied 21.1.8. Major Companies 21.2. Western Europe Anti-Asthmatics And COPD Drugs Market, Historic Market Growth, 2015 – 2019, Value ($ Million) 21.3. Western Europe Anti-Asthmatics And COPD Drugs Market, Forecast Market Growth, 2019 – 2023, 2025F, 2030F Value ($ Million) 21.4. Western Europe Anti-Asthmatics And COPD Drugs Market, Segmentation By Drug Class, Historic And Forecast, 2015 – 2019, 2023F, 2025F, 2030F, Value ($ Million) 21.5. Western Europe Anti-Asthmatics And COPD Drugs Market, Segmentation By End Users, Historic And Forecast, 2015 – 2019, 2023F, 2025F, 2030F, Value ($ Million) 21.6. Western Europe Anti-Asthmatics And COPD Drugs Market: Country Analysis 21.7. UK Anti-Asthmatics And COPD Drugs Market 21.8. UK Anti-Asthmatics And COPD Drugs Market Overview 21.8.1. Country Information 21.8.2. Market Information 21.8.3. Background Information 21.8.4. Government Initiatives 21.8.5. New Drug Trials And Approvals 21.8.6. Major Associations 21.8.7. Taxes Levied 21.8.8. Major Companies 21.9. UK Anti-Asthmatics And COPD Drugs Market, Historic Market Growth, 2015 – 2019, Value ($ Million) 21.10. UK Anti-Asthmatics And COPD Drugs Market, Forecast Market Growth, 2019 – 2023, 2025F, 2030F Value ($ Million) 21.11. UK Anti-Asthmatics And COPD Drugs Market, Segmentation By Drug Class, Historic And Forecast, 2015 – 2019, 2023F, 2025F, 2030F, Value ($ Million) 21.12. UK Anti-Asthmatics And COPD Drugs Market, Segmentation By End Users, Historic And Forecast, 2015 – 2019, 2023F, 2025F, 2030F, Value ($ Million) 21.13. Germany Anti-Asthmatics And COPD Drugs Market 21.14. Germany Anti-Asthmatics And COPD Drugs, Historic Market Growth, 2015 – 2019, Value ($ Million) 21.15. Germany Anti-Asthmatics And COPD Drugs, Forecast Market Growth, 2019 – 2023, 2025F, 2030F Value ($ Million) 21.16. Germany Anti-Asthmatics And COPD Drugs Market, Segmentation By Drug Class, Historic And Forecast, 2015 – 2019, 2023F, 2025F, 2030F, Value ($ Million) 21.17. Germany Anti-Asthmatics And COPD Drugs Market, Segmentation By End Users, Historic And Forecast, 2015 – 2019, 2023F, 2025F, 2030F, Value ($ Million) 21.18. France Anti-Asthmatics And COPD Drugs Market 21.19. France Anti-Asthmatics And COPD Drugs Market, Historic Market Growth, 2015 – 2019, Value ($ Million) 21.20. France Anti-Asthmatics And COPD Drugs Market, Forecast Market Growth, 2019 – 2023, 2025F, 2030F Value ($ Million) 21.21. France Anti-Asthmatics And COPD Drugs Market, Segmentation By Drug Class, Historic And Forecast, 2015 – 2019, 2023F, 2025F, 2030F, Value ($ Million) 21.22. France Anti-Asthmatics And COPD Drugs Market, Segmentation By End Users, Historic And Forecast, 2015 – 2019, 2023F, 2025F, 2030F, Value ($ Million) 22. Eastern Europe Anti-Asthmatics And COPD Drugs Market 22.1. Eastern Europe Anti-Asthmatics And COPD Drugs Market Overview 22.1.1. Region Information 22.1.2. Market Information 22.1.3. Background Information 22.1.4. New Drug Trials And Approvals 22.1.5. Major Associations 22.1.6. Taxes Levied 22.1.7. Major Companies 22.2. Eastern Europe Anti-Asthmatics And COPD Drugs Market, Historic Market Growth, 2015 – 2019, Value ($ Million) 22.3. Eastern Europe Anti-Asthmatics And COPD Drugs Market, Forecast Market Growth, 2019 – 2023, 2025F, 2030F Value ($ Million) 22.4. Eastern Europe Anti-Asthmatics And COPD Drugs Market, Segmentation By Drug Class, Historic And Forecast, 2015 – 2019, 2023F, 2025F, 2030F, Value ($ Million) 22.5. Eastern Europe Anti-Asthmatics And COPD Drugs Market, Segmentation By End Users, Historic And Forecast, 2015 – 2019, 2023F, 2025F, 2030F, Value ($ Million) 22.6. Russia Anti-Asthmatics And COPD Drugs Market 22.7. Russia Anti-Asthmatics And COPD Drugs Market, Historic Market Growth, 2015 – 2019, Value ($ Million) 22.8. Russia Anti-Asthmatics And COPD Drugs Market, Forecast Market Growth, 2019 – 2023, 2025F, 2030F Value ($ Million) 22.9. Russia Anti-Asthmatics And COPD Drugs Market, Segmentation By Drug Class, Historic And Forecast, 2015 – 2019, 2023F, 2025F, 2030F, Value ($ Million) 22.10. Russia Anti-Asthmatics And COPD Drugs Market, Segmentation By End Users, Historic And Forecast, 2015 – 2019, 2023F, 2025F, 2030F, Value ($ Million) 23. North America Anti-Asthmatics And COPD Drugs Market 23.1. North America Anti-Asthmatics And COPD Drugs Market Overview 23.1.1. Region Information 23.1.2. Market Information 23.1.3. Background Information 23.1.4. Government Initiatives 23.1.5. New Drug Trials And Approvals 23.1.6. Major Associations 23.1.7. Taxes Levied 23.1.8. Investments 23.1.9. Major Companies 23.2. North America Anti-Asthmatics And COPD Drugs Market, Historic Market Growth, 2015 – 2019, Value ($ Million) 23.3. North America Anti-Asthmatics And COPD Drugs Market, Forecast Market Growth, 2019 – 2023, 2025F, 2030F Value ($ Million) 23.4. North America Anti-Asthmatics And COPD Drugs Market, Segmentation By Drug Class, Historic And Forecast, 2015 – 2019, 2023F, 2025F, 2030F, Value ($ Million) 23.5. North America Anti-Asthmatics And COPD Drugs Market, Segmentation By End Users, Historic And Forecast, 2015 – 2019, 2023F, 2025F, 2030F, Value ($ Million) 23.6. North America Anti-Asthmatics And COPD Drugs Market: Country Analysis 23.7. USA Anti-Asthmatics And COPD Drugs Market 23.8. USA Anti-Asthmatics And COPD Drugs Market Overview 23.8.1. Country Information 23.8.2. Market Information 23.8.3. Background Information 23.8.4. Government Initiatives 23.8.5. Major Associations 23.8.6. Taxes Levied 23.8.7. Investments 23.8.8. Major Companies 23.9. USA Anti-Asthmatics And COPD Drugs Market, Historic Market Growth, 2015 – 2019, Value ($ Million) 23.10. USA Anti-Asthmatics And COPD Drugs Market, Forecast Market Growth, 2019 – 2023, 2025F, 2030F Value ($ Million) 23.11. USA Anti-Asthmatics And COPD Drugs Market, Segmentation By Drug Class, Historic And Forecast, 2015 – 2019, 2023F, 2025F, 2030F, Value ($ Million) 23.12. USA Anti-Asthmatics And COPD Drugs Market, Segmentation By End Users, Historic And Forecast, 2015 – 2019, 2023F, 2025F, 2030F, Value ($ Million) 24. South America Anti-Asthmatics And COPD Drugs Market 24.1. South America Anti-Asthmatics And COPD Drugs Market Overview 24.1.1. Region Information 24.1.2. Market Information 24.1.3. Background Information 24.1.4. Major Associations 24.1.5. Government Initiatives 24.1.6. Investments 24.1.7. Major Companies 24.2. South America Anti-Asthmatics And COPD Drugs Market, Historic Market Growth, 2015 – 2019, Value ($ Million) 24.3. South America Anti-Asthmatics And COPD Drugs Market, Forecast Market Growth, 2019 – 2023, 2025F, 2030F Value ($ Million) 24.4. South America Anti-Asthmatics And COPD Drugs Market, Segmentation By Drug Class, Historic And Forecast, 2015 – 2019, 2023F, 2025F, 2030F, Value ($ Million) 24.5. South America Anti-Asthmatics And COPD Drugs Market, Segmentation By End Users, Historic And Forecast, 2015 – 2019, 2023F, 2025F, 2030F, Value ($ Million) 24.6. South America Anti-Asthmatics And COPD Drugs Market: Country Analysis 24.7. Brazil Anti-Asthmatics And COPD Drugs Market 24.8. Brazil Anti-Asthmatics And COPD Drugs Market, Historic Market Growth, 2015 – 2019, Value ($ Million) 24.9. Brazil Anti-Asthmatics And COPD Drugs Market, Forecast Market Growth, 2019 – 2023, 2025F, 2030F Value ($ Million) 24.10. Brazil Anti-Asthmatics And COPD Drugs Market, Segmentation By Drug Class, Historic And Forecast, 2015 – 2019, 2023F, 2025F, 2030F, Value ($ Million) 24.11. Brazil Anti-Asthmatics And COPD Drugs Market, Segmentation By End Users, Historic And Forecast, 2015 – 2019, 2023F, 2025F, 2030F, Value ($ Million) 25. Middle East Anti-Asthmatics And COPD Drugs Market 25.1. Middle East Anti-Asthmatics And COPD Drugs Market Overview 25.1.1. Region Information 25.1.2. Market Information 25.1.3. Background Information 25.1.4. Government Initiatives 25.1.5. Major Associations 25.1.6. Taxes Levied 25.1.7. Major Companies 25.2. Middle East Anti-Asthmatics And COPD Drugs Market, Historic Market Growth, 2015 – 2019, Value ($ Million) 25.3. Middle East Anti-Asthmatics And COPD Drugs Market, Forecast Market Growth, 2019 – 2023, 2025F, 2030F Value ($ Million) 25.4. Middle East Anti-Asthmatics And COPD Drugs Market, Segmentation By Drug Class, Historic And Forecast, 2015 – 2019, 2023F, 2025F, 2030F, Value ($ Million) 25.5. Middle East Anti-Asthmatics And COPD Drugs Market, Segmentation By End Users, Historic And Forecast, 2015 – 2019, 2023F, 2025F, 2030F, Value ($ Million) 26. Africa Anti-Asthmatics And COPD Drugs Market 26.1. Africa Anti-Asthmatics And COPD Drugs Market Overview 26.1.1. Region Information 26.1.2. Market Information 26.1.3. Background Information 26.1.4. Government Initiatives 26.1.5. Major Associations 26.1.6. Taxes Levied 26.1.7. Investments 26.1.8. Major Companies 26.2. Africa Anti-Asthmatics And COPD Drugs Market, Historic Market Growth, 2015 – 2019, Value ($ Million) 26.3. Africa Anti-Asthmatics And COPD Drugs Market, Forecast Market Growth, 2019 – 2023, 2025F, 2030F Value ($ Million) 26.4. Africa Anti-Asthmatics And COPD Drugs Market, Segmentation By Drug Class, Historic And Forecast, 2015 – 2019, 2023F, 2025F, 2030F, Value ($ Million) 26.5. Africa Anti-Asthmatics And COPD Drugs Market, Segmentation By End Users, Historic And Forecast, 2015 – 2019, 2023F, 2025F, 2030F, Value ($ Million) 27. Global Anti-Asthmatics And COPD Drugs Market Competitive Landscape 27.1. Company Profiles 27.2. GlaxoSmithKline plc. 27.2.1. Company Overview 27.2.2. Products And Services 27.2.3. Business Strategy 27.2.4. Financial Overview 27.3. AstraZeneca plc. 27.3.1. Company Overview 27.3.2. Products And Services 27.3.3. Business Strategy 27.3.4. Financial Overview 27.4. Boehringer-Ingelheim GmbH 27.4.1. Company Overview 27.4.2. Products And Services 27.4.3. Business Strategy 27.4.4. Financial Overview 27.5. F. Hoffmann-La Roche Ltd 27.5.1. Company Overview 27.5.2. Products And Services 27.5.3. Business Strategy 27.5.4. Financial Overview 27.6. Novartis AG 27.6.1. Company Overview 27.6.2. Products And Services 27.6.3. Business Strategy 27.6.4. Financial Overview 28. Key Mergers And Acquisitions In The Anti-Asthmatics And COPD Drugs Market 28.1. AptarGroup, Inc. Acquired Nanopharm Ltd and Gateway Analytical 28.2. ResMed Acquired Propeller Health 28.3. Circassia Acquired AstraZeneca’s COPD Treatment Tudorza 28.4. RecipharmAB Acquired Sanofi’s Inhalation Contract Manufacturing Business 28.5. Mast Therapeutics, Inc. Merged With Savara Inc. 28.6. Mylan N.V. Acquired Majority Stake In Meda AB 28.7. Vectura Group Merged With Skyepharma 28.8. Recordati Acquired Italchimici S.p.A. 28.9. Ruthigen, Inc. Merged With Pulmatrix, Inc. 29. Market Background: Respiratory Diseases Drugs Market 29.1. Respiratory Diseases Drugs Market Characteristics 29.1.1. Market Definition 29.1.2. Segmentation By Type 29.1.3. Anti-Asthmatics And COPD Drugs 29.1.4. Cough And Cold Preparations 29.2. Global Respiratory Diseases Drugs Market, Segmentation By Type, 2015 – 2023, Value ($ Billion) 29.3. Global Respiratory Diseases Drugs Market, 2019, By Region, Value ($ Billion) 29.4. Global Respiratory Diseases Drugs Market, 2015 – 2023, Historic And Forecast, By Region 30. Anti-Asthmatics And COPD Drugs Market Opportunities And Strategies 30.1. Global Anti-Asthmatics And COPD Drugs Market In 2023 – Countries Offering Most New Opportunities 30.2. Global Anti-Asthmatics And COPD Drugs Market In 2023- Segments Offering Most New Opportunities 30.3. Global Anti-Asthmatics And COPD Drugs Market In 2023 – Growth Strategies 30.3.1. Market Trend Based Strategies 30.3.2. Competitor Strategies 31. Global Anti-Asthmatics And COPD Drugs Market Recommendations 31.1. Conclusions 31.2. Recommendations 31.2.1. Product 31.2.2. Place 31.2.3. Price 31.2.4. Promotion 32. Appendix 32.1. Market Data Sources 32.2. Research Methodology 32.3. Currencies 32.4. Research Inquiries 32.5. The Business Research Company 32.6. Copyright and Disclaimer
List of Tables Table 1: Global Anti-Asthmatics And COPD Drugs Market, Product Pipeline Analysis Table 2: Global Anti-Asthmatics And COPD Drugs Market, Top 10 Drugs Sales, 2019 Table 3: Global Anti-Asthmatics And COPD Drugs Market, Patent Analysis Of Leading Drugs, 2019 Table 4: Anti-Asthmatics And COPD Drugs Market Regulatory Landscape Table 5: Prevalence Of Asthma, 2014-2017 Table 6: Prevalence Of COPD, 2014-2017 Table 7: Global Anti-Asthmatics And COPD Drugs Market, Historic, 2015 - 2019, $ Million Table 8: Global Anti-Asthmatics And COPD Drugs Market, Forecast, 2019 - 2023, 2025F, 2030F, $ Million Table 9: Global Anti-Asthmatics And COPD Drugs Market, By Region, Historic and Forecast, 2015 - 2019, 2023F, 2025F, 2030F, % Table 10: Global Anti-Asthmatics And COPD Drugs Market, By Region, Historic and Forecast, 2015 - 2019, 2023F, 2025F, 2030F, $ Million Table 11: Global Anti-Asthmatics And COPD Drugs Market, By Country, Historic and Forecast, 2015 - 2019, 2023F, 2025F, 2030F, % Table 12: Global Anti-Asthmatics And COPD Drugs Market, By Country, Historic and Forecast, 2015 - 2019, 2023F, 2025F, 2030F, $ Million Table 13: Global Anti-Asthmatics And COPD Drugs Market, Segmentation By Drug Class, Historic And Forecast, 2015 - 2019, 2023F, 2025F, 2030F, % Table 14: Global Anti-Asthmatics And COPD Drugs Market, Segmentation By Drug Class, Historic And Forecast, 2015 - 2019, 2023F, 2025F, 2030F, $ Million Table 15: Global Anti-Asthmatics And COPD Drugs Market, Segmentation By End Users, Historic And Forecast, 2015 - 2019, 2023F, 2025F, 2030F, % Table 16: Global Anti-Asthmatics And COPD Drugs Market, Segmentation By End Users, Historic And Forecast, 2015 - 2019, 2023F, 2025F, 2030F, $ Million Table 17: Global Anti-Asthmatics And COPD Drugs Market, Segmentation By Distribution Channel, Historic And Forecast, 2015 - 2019, 2023F, 2025F, 2030F, % Table 18: Global Anti-Asthmatics And COPD Drugs Market, Segmentation By Distribution Channel, Historic And Forecast, 2015 - 2019, 2023F, 2025F, 2030F, $ Million Table 19: Global Anti-Asthmatics And COPD Drugs Market, Segmentation By Therapy, 2019 Table 20: Global Anti-Asthmatics And COPD Drugs Market, Segmentation By Route Of Administration, 2019 Table 21: Global Anti-Asthmatics And COPD Drugs Market, Segmentation By Patients’ Age Group, 2019 Table 22: Global Anti-Asthmatics And COPD Drugs Market, Segmentation By Type Of Prescription, 2019 Table 23: Global Anti-Asthmatics And COPD Drugs Market, Segmentation By Type Of Drug, 2019 Table 24: Asia-Pacific Public Healthcare Expenditure, 2015-2019, $ Billion Table 25: Asia-Pacific Private Healthcare Expenditure, 2015-2019, $ Billion Table 26: Asia-Pacific Total Population Aged 65 And Above, 2015-2023, Thousands Table 27: Air Pollution And Air Quality Index, Asia-Pacific Countries Table 28: Asia-Pacific Anti-Asthmatics And COPD Drugs Market, Historic, 2015 - 2019, $ Million Table 29: Asia-Pacific Anti-Asthmatics And COPD Drugs Market, Forecast, 2019 - 2023, 2025F, 2030F, $ Million Table 30: Asia Pacific Anti-Asthmatics And COPD Drugs Market, Segmentation By Drug Class, Historic And Forecast, 2015 - 2019, 2023F, 2025F, 2030F, % Table 31: Asia Pacific Anti-Asthmatics And COPD Drugs Market, Segmentation By Drug Class, Historic And Forecast, 2015 - 2019, 2023F, 2025F, 2030F, $ Million Table 32: Asia-Pacific Anti-Asthmatics And COPD Drugs Market, Segmentation By End Users, Historic And Forecast, 2015 - 2019, 2023F, 2025F, 2030F, % Table 33: Asia-Pacific Anti-Asthmatics And COPD Drugs Market, Segmentation By End Users, Historic And Forecast, 2015 - 2019, 2023F, 2025F, 2030F, $ Million Table 34: China Public Healthcare Expenditure And Private Healthcare Expenditure, 2015-2019, $ Billion Table 35: China Total Population Aged 65 And Above, 2015-2023, Thousands Table 36: China Anti-Asthmatics And COPD Drugs Market, Historic, 2015 - 2019, $ Million Table 37: China Anti-Asthmatics And COPD Drugs Market, Forecast, 2019 - 2023, 2025F, 2030F, $ Million Table 38: China Anti-Asthmatics And COPD Drugs Market, Segmentation By Drug Class, Historic And Forecast, 2015 - 2019, 2023F, 2025F, 2030F, % Table 39: China Anti-Asthmatics And COPD Drugs Market, Segmentation By Drug Class, Historic And Forecast, 2015 - 2019, 2023F, 2025F, 2030F, $ Million Table 40: China Anti-Asthmatics And COPD Drugs Market, Segmentation By End Users, Historic And Forecast, 2015 - 2019, 2023F, 2025F, 2030F, % Table 41: China Anti-Asthmatics And COPD Drugs Market, Segmentation By End Users, Historic And Forecast, 2015 - 2019, 2023F, 2025F, 2030F, $ Million Table 42: India Public Healthcare Expenditure And Private Healthcare Expenditure, 2015-2019, $ Billion Table 43: India Total Population Aged 65 And Above, 2015-2023, Thousands Table 44: India Anti-Asthmatics And COPD Drugs Market, Historic, 2015 - 2019, $ Million Table 45: India Anti-Asthmatics And COPD Drugs Market, Forecast, 2019 - 2023, 2025F, 2030F, $ Million Table 46: India Anti-Asthmatics And COPD Drugs Market, Segmentation By Drug Class, Historic And Forecast, 2015 - 2019, 2023F, 2025F, 2030F, % Table 47: India Anti-Asthmatics And COPD Drugs Market, Segmentation By Drug Class, Historic And Forecast, 2015 - 2019, 2023F, 2025F, 2030F, $ Million Table 48: India Anti-Asthmatics And COPD Drugs Market, Segmentation By End Users, Historic And Forecast, 2015 - 2019, 2023F, 2025F, 2030F, % Table 49: India Anti-Asthmatics And COPD Drugs Market, Segmentation By End Users, Historic And Forecast, 2015 - 2019, 2023F, 2025F, 2030F, $ Million Table 50: Japan Public Healthcare Expenditure And Private Healthcare Expenditure, 2015-2019, $ Billion Table 51: Japan Total Population Aged 65 And Above, 2015-2023, Thousands Table 52: Japan Anti-Asthmatics And COPD Drugs Market, Historic, 2015 - 2019, $ Million Table 53: Japan Anti-Asthmatics And COPD Drugs Market, Forecast, 2019 - 2023, 2025F, 2030F, $ Million Table 54: Japan Anti-Asthmatics And COPD Drugs Market, Segmentation By Drug Class, Historic And Forecast, 2015 - 2019, 2023F, 2025F, 2030F, % Table 55: Japan Anti-Asthmatics And COPD Drugs Market, Segmentation By Drug Class, Historic And Forecast, 2015 - 2019, 2023F, 2025F, 2030F, $ Million Table 56: Japan Anti-Asthmatics And COPD Drugs Market, Segmentation By End Users, Historic And Forecast, 2015 - 2019, 2023F, 2025F, 2030F, % Table 57: Japan Anti-Asthmatics And COPD Drugs Market, Segmentation By End Users, Historic And Forecast, 2015 - 2019, 2023F, 2025F, 2030F, $ Million Table 58: Australia Anti-Asthmatics And COPD Drugs Market, Historic, 2015 - 2019, $ Million Table 59: Australia Anti-Asthmatics And COPD Drugs Market, Forecast, 2019 - 2023, 2025F, 2030F, $ Million Table 60: Australia Anti-Asthmatics And COPD Drugs Market, Segmentation By Drug Class, Historic And Forecast, 2015 - 2019, 2023F, 2025F, 2030F, % Table 61: Australia Anti-Asthmatics And COPD Drugs Market, Segmentation By Drug Class, Historic And Forecast, 2015 - 2019, 2023F, 2025F, 2030F, $ Million Table 62: Australia Anti-Asthmatics And COPD Drugs Market, Segmentation By End Users, Historic And Forecast, 2015 - 2019, 2023F, 2025F, 2030F, % Table 63: Australia Anti-Asthmatics And COPD Drugs Market, Segmentation By End Users, Historic And Forecast, 2015 - 2019, 2023F, 2025F, 2030F, $ Million Table 64: Indonesia Anti-Asthmatics And COPD Drugs Market, Historic, 2015 - 2019, $ Million Table 65: Indonesia Anti-Asthmatics And COPD Drugs Market, Forecast, 2019 - 2023, 2025F, 2030F, $ Million Table 66: Indonesia Anti-Asthmatics And COPD Drugs Market, Segmentation By Drug Class, Historic And Forecast, 2015 - 2019, 2023F, 2025F, 2030F, % Table 67: Indonesia Anti-Asthmatics And COPD Drugs Market, Segmentation By Drug Class, Historic And Forecast, 2015 - 2019, 2023F, 2025F, 2030F, $ Million Table 68: Indonesia Anti-Asthmatics And COPD Drugs Market, Segmentation By End Users, Historic And Forecast, 2015 - 2019, 2023F, 2025F, 2030F, % Table 69: Indonesia Anti-Asthmatics And COPD Drugs Market, Segmentation By End Users, Historic And Forecast, 2015 - 2019, 2023F, 2025F, 2030F, $ Million Table 70: South Korea Anti-Asthmatics And COPD Drugs Market, Historic, 2015 - 2019, $ Million Table 71: South Korea Anti-Asthmatics And COPD Drugs Market, Forecast, 2019 - 2023, 2025F, 2030F, $ Million Table 72: South Korea Anti-Asthmatics And COPD Drugs Market, Segmentation By Drug Class, Historic And Forecast, 2015 - 2019, 2023F, 2025F, 2030F, % Table 73: South Korea Anti-Asthmatics And COPD Drugs Market, Segmentation By Drug Class, Historic And Forecast, 2015 - 2019, 2023F, 2025F, 2030F, $ Million Table 74: South Korea Anti-Asthmatics And COPD Drugs Market, Segmentation By End Users, Historic And Forecast, 2015 - 2019, 2023F, 2025F, 2030F, % Table 75: South Korea Anti-Asthmatics And COPD Drugs Market, Segmentation By End Users, Historic And Forecast, 2015 - 2019, 2023F, 2025F, 2030F, $ Million Table 76: Western Europe Public Healthcare Expenditure, 2015-2019, $ Billion Table 77: Western Europe Private Healthcare Expenditure, 2015-2019, $ Billion Table 78: Western Europe Total Population Aged 65 And Above, 2015-2023, Thousands Table 79: Air Pollution And Air Quality Index in 2018, Western Europe Countries Table 80: Western Europe Anti-Asthmatics And COPD Drugs Market, Historic, 2015 - 2019, $ Million Table 81: Western Europe Anti-Asthmatics And COPD Drugs Market, Forecast, 2019 - 2023, 2025F, 2030F, $ Million Table 82: Western Europe Anti-Asthmatics And COPD Drugs Market, Segmentation By Drug Class, Historic And Forecast, 2015 - 2019, 2023F, 2025F, 2030F, % Table 83: Western Europe Anti-Asthmatics And COPD Drugs Market, Segmentation By Drug Class, Historic And Forecast, 2015 - 2019, 2023F, 2025F, 2030F, $ Million Table 84: Western Europe Anti-Asthmatics And COPD Drugs Market, Segmentation By End Users, Historic And Forecast, 2015 - 2019, 2023F, 2025F, 2030F, % Table 85: Western Europe Anti-Asthmatics And COPD Drugs Market, Segmentation By End Users, Historic And Forecast, 2015 - 2019, 2023F, 2025F, 2030F, $ Million Table 86: UK Public Healthcare Expenditure And Private Healthcare Expenditure, 2015-2019, $ Billion Table 87: UK Total Population Aged 65 And Above, 2015-2023, Thousands Table 88: UK Anti-Asthmatics And COPD Drugs Market, Historic, 2015 - 2019, $ Million Table 89: UK Anti-Asthmatics And COPD Drugs Market, Forecast, 2019 - 2023, 2025F, 2030F, $ Million Table 90: UK Anti-Asthmatics And COPD Drugs Market, Segmentation By Drug Class, Historic And Forecast, 2015 - 2019, 2023F, 2025F, 2030F, % Table 91: UK Anti-Asthmatics And COPD Drugs Market, Segmentation By Drug Class, Historic And Forecast, 2015 - 2019, 2023F, 2025F, 2030F, $ Million Table 92: UK Anti-Asthmatics And COPD Drugs Market, Segmentation By End Users, Historic And Forecast, 2015 - 2019, 2023F, 2025F, 2030F, % Table 93: UK Anti-Asthmatics And COPD Drugs Market, Segmentation By End Users, Historic And Forecast, 2015 - 2019, 2023F, 2025F, 2030F, $ Million Table 94: Germany Anti-Asthmatics And COPD Drugs Market, Historic, 2015 - 2019, $ Million Table 95: Germany Anti-Asthmatics And COPD Drugs Market, Forecast, 2019 - 2023, 2025F, 2030F, $ Million Table 96: Germany Anti-Asthmatics And COPD Drugs Market, Segmentation By Drug Class, Historic And Forecast, 2015 - 2019, 2023F, 2025F, 2030F, % Table 97: Germany Anti-Asthmatics And COPD Drugs Market, Segmentation By Drug Class, Historic And Forecast, 2015 - 2019, 2023F, 2025F, 2030F, $ Million Table 98: Germany Anti-Asthmatics And COPD Drugs Market, Segmentation By End Users, Historic And Forecast, 2015 - 2019, 2023F, 2025F, 2030F, % Table 99: Germany Anti-Asthmatics And COPD Drugs Market, Segmentation By End Users, Historic And Forecast, 2015 - 2019, 2023F, 2025F, 2030F, $ Million Table 100: France Anti-Asthmatics And COPD Drugs Market, Historic, 2015 - 2019, $ Million Table 101: France Anti-Asthmatics And COPD Drugs Market, Forecast, 2019 - 2023, 2025F, 2030F, $ Million Table 102: France Anti-Asthmatics And COPD Drugs Market, Segmentation By Drug Class, Historic And Forecast, 2015 - 2019, 2023F, 2025F, 2030F, % Table 103: France Anti-Asthmatics And COPD Drugs Market, Segmentation By Drug Class, Historic And Forecast, 2015 - 2019, 2023F, 2025F, 2030F, $ Million Table 104: France Anti-Asthmatics And COPD Drugs Market, Segmentation By End Users, Historic And Forecast, 2015 - 2019, 2023F, 2025F, 2030F, % Table 105: France Anti-Asthmatics And COPD Drugs Market, Segmentation By End Users, Historic And Forecast, 2015 - 2019, 2023F, 2025F, 2030F, $ Million Table 106: Eastern Europe Public Healthcare Expenditure, 2015-2019, $ Billion Table 107: Eastern Europe Private Healthcare Expenditure, 2015-2019, $ Billion Table 108: Eastern Europe Total Population Aged 65 And Above, 2015-2023, Thousands Table 109: Eastern Europe Anti-Asthmatics And COPD Drugs Market, Historic, 2015 - 2019, $ Million Table 110: Eastern Europe Anti-Asthmatics And COPD Drugs Market, Forecast, 2019 - 2023, 2025F, 2030F, $ Million Table 111: Eastern Europe Anti-Asthmatics And COPD Drugs Market, Segmentation By Drug Class, Historic And Forecast, 2015 - 2019, 2023F, 2025F, 2030F, % Table 112: Eastern Europe Anti-Asthmatics And COPD Drugs Market, Segmentation By Drug Class, Historic And Forecast, 2015 - 2019, 2023F, 2025F, 2030F, $ Million Table 113: Eastern Europe Anti-Asthmatics And COPD Drugs Market, Segmentation By End Users, Historic And Forecast, 2015 - 2019, 2023F, 2025F, 2030F, % Table 114: Eastern Europe Anti-Asthmatics And COPD Drugs Market, Segmentation By End Users, Historic And Forecast, 2015 - 2019, 2023F, 2025F, 2030F, $ Million Table 115: Russia Anti-Asthmatics And COPD Drugs Market, Historic, 2015 - 2019, $ Million Table 116: Russia Anti-Asthmatics And COPD Drugs Market, Forecast, 2019 - 2023, 2025F, 2030F, $ Million Table 117: Russia Anti-Asthmatics And COPD Drugs Market, Segmentation By Drug Class, Historic And Forecast, 2015 - 2019, 2023F, 2025F, 2030F, % Table 118: Russia Anti-Asthmatics And COPD Drugs Market, Segmentation By Drug Class, Historic And Forecast, 2015 - 2019, 2023F, 2025F, 2030F, $ Million Table 119: Russia Anti-Asthmatics And COPD Drugs Market, Segmentation By End Users, Historic And Forecast, 2015 - 2019, 2023F, 2025F, 2030F, % Table 120: Russia Anti-Asthmatics And COPD Drugs Market, Segmentation By End Users, Historic And Forecast, 2015 - 2019, 2023F, 2025F, 2030F, $ Million Table 121: North America Public Healthcare Expenditure, 2015-2019, $ Billion Table 122: North America Private Healthcare Expenditure, 2013-2017, $ Billion Table 123: North America Total Population Aged 65 And Above, 2015-2023, Thousands Table 124: North America Anti-Asthmatics And COPD Drugs Market, Historic, 2015 - 2019, $ Million Table 125: North America Anti-Asthmatics And COPD Drugs Market, Forecast, 2019 - 2023, 2025F, 2030F, $ Million Table 126: North America Anti-Asthmatics And COPD Drugs Market, Segmentation By Drug Class, Historic And Forecast, 2015 - 2019, 2023F, 2025F, 2030F, % Table 127: North America Anti-Asthmatics And COPD Drugs Market, Segmentation By Drug Class, Historic And Forecast, 2015 - 2019, 2023F, 2025F, 2030F, $ Million Table 128: North America Anti-Asthmatics And COPD Drugs Market, Segmentation By End Users, Historic And Forecast, 2015 - 2019, 2023F, 2025F, 2030F, % Table 129: North America Anti-Asthmatics And COPD Drugs Market, Segmentation By End Users, Historic And Forecast, 2015 - 2019, 2023F, 2025F, 2030F, $ Million Table 130: USA Public Healthcare Expenditure And Private Healthcare Expenditure, 2015-2019, $ Billion Table 131: USA Total Population Aged 65 And Above, 2015-2023, Thousands Table 132: USA Anti-Asthmatics And COPD Drugs Market, Historic, 2015 - 2019, $ Million Table 133: USA Anti-Asthmatics And COPD Drugs Market, Forecast, 2019 - 2023, 2025F, 2030F, $ Million Table 134: USA Anti-Asthmatics And COPD Drugs Market, Segmentation By Drug Class, Historic And Forecast, 2015 - 2019, 2023F, 2025F, 2030F, % Table 135: USA Anti-Asthmatics And COPD Drugs Market, Segmentation By Drug Class, Historic And Forecast, 2015 - 2019, 2023F, 2025F, 2030F, $ Million Table 136: USA Anti-Asthmatics And COPD Drugs Market, Segmentation By End Users, Historic And Forecast, 2015 - 2019, 2023F, 2025F, 2030F, % Table 137: USA Anti-Asthmatics And COPD Drugs Market, Segmentation By End Users, Historic And Forecast, 2015 - 2019, 2023F, 2025F, 2030F, $ Million Table 138: South America Public Healthcare Expenditure, 2015-2019, $ Billion Table 139: South America Private Healthcare Expenditure, 2015-2019, $ Billion Table 140: South America Total Population Aged 65 And Above, 2015-2023, Thousands Table 141: South America Anti-Asthmatics And COPD Drugs Market, Historic, 2015 - 2019, $ Million Table 142: South America Anti-Asthmatics And COPD Drugs Market, Forecast, 2019 - 2023, 2025F, 2030F, $ Million Table 143: South America Anti-Asthmatics And COPD Drugs Market, Segmentation By Drug Class, Historic And Forecast, 2015 - 2019, 2023F, 2025F, 2030F, % Table 144: South America Anti-Asthmatics And COPD Drugs Market, Segmentation By Drug Class, Historic And Forecast, 2015 - 2019, 2023F, 2025F, 2030F, $ Million Table 145: South America Anti-Asthmatics And COPD Drugs Market, Segmentation By End Users, Historic And Forecast, 2015 - 2019, 2023F, 2025F, 2030F, % Table 146: South America Anti-Asthmatics And COPD Drugs Market, Segmentation By End Users, Historic And Forecast, 2015 - 2019, 2023F, 2025F, 2030F, $ Million Table 147: Brazil Anti-Asthmatics And COPD Drugs Market, Historic, 2015 - 2019, $ Million Table 148: Brazil Anti-Asthmatics And COPD Drugs Market, Forecast, 2019 - 2023, 2025F, 2030F, $ Million Table 149: Brazil Anti-Asthmatics And COPD Drugs Market, Segmentation By Drug Class, Historic And Forecast, 2015 - 2019, 2023F, 2025F, 2030F, % Table 150: Brazil Anti-Asthmatics And COPD Drugs Market, Segmentation By Drug Class, Historic And Forecast, 2015 - 2019, 2023F, 2025F, 2030F, $ Million Table 151: Brazil Anti-Asthmatics And COPD Drugs Market, Segmentation By End Users, Historic And Forecast, 2015 - 2019, 2023F, 2025F, 2030F, % Table 152: Brazil Anti-Asthmatics And COPD Drugs Market, Segmentation By End Users, Historic And Forecast, 2015 - 2019, 2023F, 2025F, 2030F, $ Million Table 153: Middle East Public Healthcare Expenditure, 2015-2019, $ Billion Table 154: Middle East Private Healthcare Expenditure, 2015-2019, $ Billion Table 155: Middle East Total Population Aged 65 And Above, 2015-2023, Thousands Table 156: Middle East Anti-Asthmatics And COPD Drugs Market, Historic, 2015 - 2019, $ Million Table 157: Middle East Anti-Asthmatics And COPD Drugs Market, Forecast, 2019 - 2023, 2025F, 2030F, $ Million Table 158: Middle East Anti-Asthmatics And COPD Drugs Market, Segmentation By Drug Class, Historic And Forecast, 2015 - 2019, 2023F, 2025F, 2030F, % Table 159: Middle East Anti-Asthmatics And COPD Drugs Market, Segmentation By Drug Class, Historic And Forecast, 2015 - 2019, 2023F, 2025F, 2030F, $ Million Table 160: Middle East Anti-Asthmatics And COPD Drugs Market, Segmentation By End Users, Historic And Forecast, 2015 - 2019, 2023F, 2025F, 2030F, % Table 161: Middle East Anti-Asthmatics And COPD Drugs Market, Segmentation By End Users, Historic And Forecast, 2015 - 2019, 2023F, 2025F, 2030F, $ Million Table 162: Africa Public Healthcare Expenditure, 2015-2019, $ Billion Table 163: Africa Private Healthcare Expenditure, 2015-2019, $ Billion Table 164: Africa Total Population Aged 65 And Above, 2015-2023, Thousands Table 165: Africa Anti-Asthmatics And COPD Drugs Market, Historic, 2015 - 2019, $ Million Table 166: Africa Anti-Asthmatics And COPD Drugs Market, Forecast, 2019 - 2023, 2025F, 2030F, $ Million Table 167: Africa Anti-Asthmatics And COPD Drugs Market, Segmentation By Drug Class, Historic And Forecast, 2015 - 2019, 2023F, 2025F, 2030F, % Table 168: Africa Anti-Asthmatics And COPD Drugs Market, Segmentation By Drug Class, Historic And Forecast, 2015 - 2019, 2023F, 2025F, 2030F, $ Million Table 169: Africa Anti-Asthmatics And COPD Drugs Market, Segmentation By End Users, Historic And Forecast, 2015 - 2019, 2023F, 2025F, 2030F, % Table 170: Africa Anti-Asthmatics And COPD Drugs Market, Segmentation By End Users, Historic And Forecast, 2015 - 2019, 2023F, 2025F, 2030F, $ Million Table 171: Global Anti-Asthmatics And COPD Drugs Market, Key Competitor Estimated Market Shares, 2019, Percentage (%) Table 172: GlaxoSmithKline - Financial Performance, 2015 - 2019, $ Billion Table 173: AstraZeneca plc. - Financial Performance2015 - 2019, $ Billion Table 174: Boehringer Ingelheim GmbH - Financial Performance, 2015 - 2019, $ Billion Table 175: F. Hoffmann-La Roche Ltd. - Financial Performance, 2015 - 2019, $ Billion Table 176: Novartis AG - Financial Performance, 2015 - 2019, $ Billion Table 177: Global Respiratory Diseases Drugs Market, Segmentation By Type, 2015 - 2023, $ Billion Table 178: Global Respiratory Diseases Drugs Market, 2019, Split By Region Table 179: Global Respiratory Diseases Drugs Market, 2015 - 2023, Historic And Forecast Growth Rate, Split By Region Table 180: Anti-Asthmatics And COPD Drugs Market Size Gain ($ Million), 2019 - 2023, By Country Table 181: Anti-Asthmatics And COPD Drugs Market Size Gain ($ Million), 2019 - 2023, Segmentation By Drug Class Table 182: Anti-Asthmatics And COPD Drugs Market Size Gain ($ Million), 2019 - 2023, By Type Of End User Table 183: Anti-Asthmatics And COPD Drugs Market Size Gain ($ Million), 2019 - 2023, By Distribution Channel Table 184: Anti-Asthmatics And COPD Drugs Market Data Sources
List of Figures Figure 1: Global Anti-Asthmatics And COPD Drugs Market Segmentation By Drug Class Figure 2: Global Anti-Asthmatics And COPD Drugs Market Segmentation By End User Figure 3: Global Anti-Asthmatics And COPD Drugs Market Segmentation By Distribution Channel Figure 4: Global Anti-Asthmatics And COPD Drugs Market Segmentation By Therapy Figure 5: Global Anti-Asthmatics And COPD Drugs Market Segmentation By Route Of Administration Figure 6: Global Anti-Asthmatics And COPD Drugs Market Segmentation By Age Group Figure 7: Global Anti-Asthmatics And COPD Drugs Market Segmentation By Prescription Figure 8: Global Anti-Asthmatics And COPD Drugs Market Segmentation By Drug Type Figure 9: Market Supply Chain For Anti-Asthmatics And COPD Drugs Figure 10: Global Anti-Asthmatics And COPD Drugs Market, Historic, 2015 - 2019, $ Million Figure 11: Global Anti-Asthmatics And COPD Drugs Market, Forecast, 2019 - 2023, 2025F, 2030F, $ Million Figure 12: Global Anti-Asthmatics And COPD Drugs Market, By Region, Historic and Forecast, 2015 - 2019, 2023F, 2025F, 2030F, % Figure 13: Global Anti-Asthmatics And COPD Drugs Market, By Country, Historic and Forecast, 2015 - 2019, 2023F, 2025F, 2030F, % Figure 14: Global Anti-Asthmatics And COPD Drugs Market, Segmentation By Drug Class, Historic And Forecast, 2015 - 2019, 2023F, 2025F, 2030F, % Figure 15: Global Anti-Asthmatics And COPD Drugs Market, Segmentation By End Users, Historic And Forecast, 2015 - 2019, 2023F, 2025F, 2030F, % Figure 16: Global Anti-Asthmatics And COPD Drugs Market, Segmentation By Distribution Channel, Historic And Forecast, 2015 - 2019, 2023F, 2025F, 2030F, % Figure 17: Global Anti-Asthmatics And COPD Drugs Market, Segmentation By Therapy, 2019 Figure 18: Global Anti-Asthmatics And COPD Drugs Market, Segmentation By Route Of Administration, 2019 Figure 19: Global Anti-Asthmatics And COPD Drugs Market, Segmentation By Patients’ Age Group, 2019 Figure 20: Global Anti-Asthmatics And COPD Drugs Market, Segmentation By Type Of Prescription, 2019 Figure 21: Global Anti-Asthmatics And COPD Drugs Market, Segmentation By Type Of Drug, 2019 Figure 22: Asia-Pacific Anti-Asthmatics And COPD Drugs Market, Historic, 2015 - 2019, $ Million Figure 23: Asia-Pacific Anti-Asthmatics And COPD Drugs Market, Forecast, 2019 - 2023, 2025F, 2030F, $ Million Figure 24: Asia-Pacific Anti-Asthmatics And COPD Drugs Market, Segmentation By Drug Class, Historic And Forecast, 2015 - 2019, 2023F, 2025F, 2030F, % Figure 25: Asia-Pacific Anti-Asthmatics And COPD Drugs Market, Segmentation By End Users, Historic And Forecast, 2015 - 2019, 2023F, 2025F, 2030F, % Figure 26: China Anti-Asthmatics And COPD Drugs Market, Historic, 2015 - 2019, $ Million Figure 27: China Anti-Asthmatics And COPD Drugs Market, Forecast, 2019 - 2023, 2025F, 2030F, $ Million Figure 28: China Anti-Asthmatics And COPD Drugs Market, Segmentation By Drug Class, Historic And Forecast, 2015 - 2019, 2023F, 2025F, 2030F, % Figure 29: China Anti-Asthmatics And COPD Drugs Market, Segmentation By End Users, Historic And Forecast, 2015 - 2019, 2023F, 2025F, 2030F, % Figure 30: India Anti-Asthmatics And COPD Drugs Market, Historic, 2015 - 2019, $ Million Figure 31: India Anti-Asthmatics And COPD Drugs Market, Forecast, 2019 - 2023, 2025F, 2030F, $ Million Figure 32: India Anti-Asthmatics And COPD Drugs Market, Segmentation By Drug Class, Historic And Forecast, 2015 - 2019, 2023F, 2025F, 2030F, % Figure 33: India Anti-Asthmatics And COPD Drugs Market, Segmentation By End Users, Historic And Forecast, 2015 - 2019, 2023F, 2025F, 2030F, % Figure 34: Japan Anti-Asthmatics And COPD Drugs Market, Historic, 2015 - 2019, $ Million Figure 35: Japan Anti-Asthmatics And COPD Drugs Market, Forecast, 2019 - 2023, 2025F, 2030F, $ Million Figure 36: Japan Anti-Asthmatics And COPD Drugs Market, Segmentation By Drug Class, Historic And Forecast, 2015 - 2019, 2023F, 2025F, 2030F, % Figure 37: Japan Anti-Asthmatics And COPD Drugs Market, Segmentation By End Users, Historic And Forecast, 2015 - 2019, 2023F, 2025F, 2030F, % Figure 38: Australia Anti-Asthmatics And COPD Drugs Market, Historic, 2015 - 2019, $ Million Figure 39: Australia Anti-Asthmatics And COPD Drugs Market, Forecast, 2019 - 2023, 2025F, 2030F, $ Million Figure 40: Australia Anti-Asthmatics And COPD Drugs Market, Segmentation By Drug Class, Historic And Forecast, 2015 - 2019, 2023F, 2025F, 2030F, % Figure 41: Australia Anti-Asthmatics And COPD Drugs Market, Segmentation By End Users, Historic And Forecast, 2015 - 2019, 2023F, 2025F, 2030F, % Figure 42: Indonesia Anti-Asthmatics And COPD Drugs Market, Historic, 2015 - 2019, $ Million Figure 43: Indonesia Anti-Asthmatics And COPD Drugs Market, Forecast, 2019 - 2023, 2025F, 2030F, $ Million Figure 44: Indonesia Anti-Asthmatics And COPD Drugs Market, Segmentation By Drug Class, Historic And Forecast, 2015 - 2019, 2023F, 2025F, 2030F, % Figure 45: Indonesia Anti-Asthmatics And COPD Drugs Market, Segmentation By End Users, Historic And Forecast, 2015 - 2019, 2023F, 2025F, 2030F, % Figure 46: South Korea Anti-Asthmatics And COPD Drugs Market, Historic, 2015 - 2019, $ Million Figure 47: South Korea Anti-Asthmatics And COPD Drugs Market, Forecast, 2019 - 2023, 2025F, 2030F, $ Million Figure 48: South Korea Anti-Asthmatics And COPD Drugs Market, Segmentation By Drug Class, Historic And Forecast, 2015 - 2019, 2023F, 2025F, 2030F, % Figure 49: South Korea Anti-Asthmatics And COPD Drugs Market, Segmentation By End Users, Historic And Forecast, 2015 - 2019, 2023F, 2025F, 2030F, % Figure 50: Western Europe Anti-Asthmatics And COPD Drugs Market, Historic, 2015 - 2019, $ Million Figure 51: Western Europe Anti-Asthmatics And COPD Drugs Market, Forecast, 2019 - 2023, 2025F, 2030F, $ Million Figure 52: Western Europe Anti-Asthmatics And COPD Drugs Market, Segmentation By Drug Class, Historic And Forecast, 2015 - 2019, 2023F, 2025F, 2030F, % Figure 53: Western Europe Anti-Asthmatics And COPD Drugs Market, Segmentation By End Users, Historic And Forecast, 2015 - 2019, 2023F, 2025F, 2030F, % Figure 54: UK Anti-Asthmatics And COPD Drugs Market, Historic, 2015 - 2019, $ Million Figure 55: UK Anti-Asthmatics And COPD Drugs Market, Forecast, 2019 - 2023, 2025F, 2030F, $ Million Figure 56: UK Anti-Asthmatics And COPD Drugs Market, Segmentation By Drug Class, Historic And Forecast, 2015 - 2019, 2023F, 2025F, 2030F, % Figure 57: UK Anti-Asthmatics And COPD Drugs Market, Segmentation By End Users, Historic And Forecast, 2015 - 2019, 2023F, 2025F, 2030F, % Figure 58: Germany Anti-Asthmatics And COPD Drugs Market, Historic, 2015 - 2019, $ Million Figure 59: Germany Anti-Asthmatics And COPD Drugs Market, Forecast, 2019 - 2023, 2025F, 2030F, $ Million Figure 60: Germany Anti-Asthmatics And COPD Drugs Market, Segmentation By Drug Class, Historic And Forecast, 2015 - 2019, 2023F, 2025F, 2030F, % Figure 61: Germany Anti-Asthmatics And COPD Drugs Market, Segmentation By End Users, Historic And Forecast, 2015 - 2019, 2023F, 2025F, 2030F, % Figure 62: France Anti-Asthmatics And COPD Drugs Market, Historic, 2015 - 2019, $ Million Figure 63: France Anti-Asthmatics And COPD Drugs Market, Forecast, 2019 - 2023, 2025F, 2030F, $ Million Figure 64: France Anti-Asthmatics And COPD Drugs Market, Segmentation By Drug Class, Historic And Forecast, 2015 - 2019, 2023F, 2025F, 2030F, % Figure 65: France Anti-Asthmatics And COPD Drugs Market, Segmentation By End Users, Historic And Forecast, 2015 - 2019, 2023F, 2025F, 2030F, % Figure 66: Eastern Europe Anti-Asthmatics And COPD Drugs Market, Historic, 2015 - 2019, $ Million Figure 67: Eastern Europe Anti-Asthmatics And COPD Drugs Market, Forecast, 2019 - 2023, 2025F, 2030F, $ Million Figure 68: Eastern Europe Anti-Asthmatics And COPD Drugs Market, Segmentation By Drug Class, Historic And Forecast, 2015 - 2019, 2023F, 2025F, 2030F, % Figure 69: Eastern Europe Anti-Asthmatics And COPD Drugs Market, Segmentation By End Users, Historic And Forecast, 2015 - 2019, 2023F, 2025F, 2030F, % Figure 70: Russia Anti-Asthmatics And COPD Drugs Market, Historic, 2015 - 2019, $ Million Figure 71: Russia Anti-Asthmatics And COPD Drugs Market, Forecast, 2019 - 2023, 2025F, 2030F, $ Million Figure 72: Russia Anti-Asthmatics And COPD Drugs Market, Segmentation By Drug Class, Historic And Forecast, 2015 - 2019, 2023F, 2025F, 2030F, % Figure 73: Russia Anti-Asthmatics And COPD Drugs Market, Segmentation By End Users, Historic And Forecast, 2015 - 2019, 2023F, 2025F, 2030F, % Figure 74: North America Anti-Asthmatics And COPD Drugs Market, Historic, 2015 - 2019, $ Million Figure 75: North America Anti-Asthmatics And COPD Drugs Market, Forecast, 2019 - 2023, 2025F, 2030F, $ Million Figure 76: North America Anti-Asthmatics And COPD Drugs Market, Segmentation By Drug Class, Historic And Forecast, 2015 - 2019, 2023F, 2025F, 2030F, % Figure 77: North America Anti-Asthmatics And COPD Drugs Market, Segmentation By End Users, Historic And Forecast, 2015 - 2019, 2023F, 2025F, 2030F, % Figure 78: USA Anti-Asthmatics And COPD Drugs Market, Historic, 2015 - 2019, $ Million Figure 79: USA Anti-Asthmatics And COPD Drugs Market, Forecast, 2019 - 2023, 2025F, 2030F, $ Million Figure 80: USA Anti-Asthmatics And COPD Drugs Market, Segmentation By Drug Class, Historic And Forecast, 2015 - 2019, 2023F, 2025F, 2030F, % Figure 81: USA Anti-Asthmatics And COPD Drugs Market, Segmentation By End Users, Historic And Forecast, 2015 - 2019, 2023F, 2025F, 2030F, % Figure 82: South America Anti-Asthmatics And COPD Drugs Market, Historic, 2015 - 2019, $ Million Figure 83: South America Anti-Asthmatics And COPD Drugs Market, Forecast, 2019 - 2023, 2025F, 2030F, $ Million Figure 84: South America Anti-Asthmatics And COPD Drugs Market, Segmentation By Drug Class, Historic And Forecast, 2015 - 2019, 2023F, 2025F, 2030F, % Figure 85: South America Anti-Asthmatics And COPD Drugs Market, Segmentation By End Users, Historic And Forecast, 2015 - 2019, 2023F, 2025F, 2030F, % Figure 86: Brazil Anti-Asthmatics And COPD Drugs Market, Historic, 2015 - 2019, $ Million Figure 87: Brazil Anti-Asthmatics And COPD Drugs Market, Forecast, 2019 - 2023, 2025F, 2030F, $ Million Figure 88: Brazil Anti-Asthmatics And COPD Drugs Market, Segmentation By Drug Class, Historic And Forecast, 2015 - 2019, 2023F, 2025F, 2030F, % Figure 89: Brazil Anti-Asthmatics And COPD Drugs Market, Segmentation By End Users, Historic And Forecast, 2015 - 2019, 2023F, 2025F, 2030F, % Figure 90: Middle East Anti-Asthmatics And COPD Drugs Market, Historic, 2015 - 2019, $ Million Figure 91: Middle East Anti-Asthmatics And COPD Drugs Market, Forecast, 2019 - 2023, 2025F, 2030F, $ Million Figure 92: Middle East Anti-Asthmatics And COPD Drugs Market, Segmentation By Drug Class, Historic And Forecast, 2015 - 2019, 2023F, 2025F, 2030F, % Figure 93: Middle East Anti-Asthmatics And COPD Drugs Market, Segmentation By End Users, Historic And Forecast, 2015 - 2019, 2023F, 2025F, 2030F, % Figure 94: Africa Anti-Asthmatics And COPD Drugs Market, Historic, 2015 - 2019, $ Million Figure 95: Africa Anti-Asthmatics And COPD Drugs Market, Forecast, 2019 - 2023, 2025F, 2030F, $ Million Figure 96: Africa Anti-Asthmatics And COPD Drugs Market, Segmentation By Drug Class, Historic And Forecast, 2015 - 2019, 2023F, 2025F, 2030F, % Figure 97: Africa Anti-Asthmatics And COPD Drugs Market, Segmentation By End Users, Historic And Forecast, 2015 - 2019, 2023F, 2025F, 2030F, % Figure 98: Global Anti-Asthmatics And COPD Drugs Market, Key Competitor Estimated Market Shares, 2019, Percentage (%) Figure 99: GlaxoSmithKline - Financial Performance, 2015 - 2019, $ Billion Figure 100: AstraZeneca plc. - Financial Performance2015 - 2019, $ Billion Figure 101: Boehringer Ingelheim GmbH - Financial Performance, 2015 - 2019, $ Billion Figure 102: F. Hoffmann-La Roche Ltd - Financial Performance, 2015 - 2019, $ Billion Figure 103: Novartis AG - Financial Performance, 2015 - 2019, $ Billion Figure 104: Global Respiratory Diseases Drugs Market, Segmentation By Type, 2015 - 2023, $ Billion Figure 105: Global Respiratory Diseases Drugs Market, 2019, Split By Region Figure 106: Global Respiratory Diseases Drugs Market, 2015 - 2023, Historic And Forecast Growth Rate, Split By Region
Speak to the report author to design an exclusive study to serve your research needs.
Your personal and confidential information is safe and secure.